IntroductionA growing population of adults living with severe, chronic childhood-onset health
conditions has created a need for specialized health care delivered by providers who have …

Introduction Great variation exists in the progression and outcomes of cystic fibrosis (CF)
lung disease, due to both genetic and environmental influences. Social determinants …

11 Somayaji R, Russell R, Cogen JD, Goss CH, Nick SE, Saavedra MT, et al. Oral
azithromycin use and the recovery of lung function from pulmonary exacerbations treated …

Rationale: Health insurance coverage has been implicated as a socioeconomic factor
affecting clinical outcomes in patients with cystic fibrosis (CF), but evidence for this is mixed …

In cross-sectional data, gaps in health insurance coverage are associated with worse health
and lower utilization of preventive services. The authors investigated if these associations …

Background: The impact of specialty pediatric palliative care (PPC) on intensive care unit
(ICU) length of stay for children is unclear. Objective: To estimate the impact of PPC …

Cystic fibrosis (CF), the second most common lifeshortening autosomal recessive genetic
disorder in the United States, is characterized by abnormal secretions in multiple organ …

Background As the life expectancy of the cystic fibrosis (CF) population is lengthening with
modulator therapies, diligent age-appropriate screening and preventive care are …

Significant advancements in the treatment of cystic fibrosis (CF) have led to drastically
improved medical outcomes for those living with this illness. While these improvements have …

Introduction Cystic fibrosis (CF), an inherited autosomal recessive disease that results in the
accumulation of mucus and damage primarily to the respiratory and digestive tracts is …